Dr. Harris is a renowned expert on the
role of COX - 2
in chronic inflammation and
in promoting tumorigenesis and angiogenesis, and has authored numerous papers
in peer - reviewed journals and book chapters on the use of NSAIDS and selective COX - 2 inhibitors
in the
chemoprevention of various
cancer types.